RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Price, Quote, News and Overview
NASDAQ:RANI - Nasdaq - US7530181004 - Common Stock - Currency: USD
RANI Quote, Performance and Key Statistics
RANI THERAPEUTICS HOLDINGS-A
NASDAQ:RANI (2/6/2025, 3:18:52 PM)
1.735
+0.3 (+20.49%)
The current stock price of RANI is 1.735 USD. In the past month the price decreased by -3.36%. In the past year, price decreased by -62.01%.
RANI Latest News, Press Releases and Analysis
Thursday's session: gap up and gap down stocks
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
Which stocks are moving before the opening bell on Thursday?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
These stocks are moving in today's after hours session
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new...
RANI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 85.45 | 824.95B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.14 | 385.58B | ||
| JNJ | JOHNSON & JOHNSON | 15.42 | 370.99B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 19.07 | 225.33B | ||
| MRK | MERCK & CO. INC. | 11.6 | 224.23B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.49 | 213.57B | ||
| PFE | PFIZER INC | 8.31 | 146.46B | ||
| SNY | SANOFI-ADR | 13.34 | 133.73B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.95 | 116.15B | ||
| ZTS | ZOETIS INC | 30.27 | 78.66B | ||
| GSK | GSK PLC-SPON ADR | 7.87 | 74.48B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 30.92 | 43.13B |
Related stock screener links
About RANI
Company Profile
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company is headquartered in San Jose, California and currently employs 140 full-time employees. The company went IPO on 2021-07-30. The firm is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The RaniPill GO, is designed to deliver up to a three micrograms (mg) dose of drug with high bioavailability. The capsule includes a coating designed to withstand stomach acid but dissolve in the jejunum portion of the small intestine. Its pipeline includes RT-102, RT-105, RT-111 and RT-110. The company is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC, which is intended to enable delivery of drug payloads up to 200uL in liquid form with high bioavailability.
Company Info
RANI THERAPEUTICS HOLDINGS-A
2051 Ringwood Avenue
San Jose CALIFORNIA US
CEO: Talat Imran
Employees: 140
Company Website: https://www.ranitherapeutics.com/
Investor Relations: https://ir.ranitherapeutics.com/
Phone: 14084573700
RANI FAQ
What is the stock price of RANI?
The current stock price of RANI is 1.735 USD.
What is the symbol for RANI THERAPEUTICS HOLDINGS-A stock?
The exchange symbol of RANI THERAPEUTICS HOLDINGS-A is RANI and it is listed on the Nasdaq exchange.
On which exchange is RANI stock listed?
RANI stock is listed on the Nasdaq exchange.
Is RANI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RANI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RANI.
Does RANI stock pay dividends?
RANI does not pay a dividend.
What is the Price/Earnings (PE) ratio of RANI?
RANI does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).
What is the Short Interest ratio of RANI stock?
The outstanding short interest for RANI is 8.27% of its float.
RANI Technical Analysis
RANI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to RANI. Both the profitability and financial health of RANI have multiple concerns.
RANI Financial Highlights
Over the last trailing twelve months RANI reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS decreased by 24.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -64.7% | ||
| ROE | -902.85% | ||
| Debt/Equity | 4.34 |
RANI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to RANI. The Buy consensus is the average rating of analysts ratings from 13 analysts.